Skip to content
Advertisement

A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Sprout has succeeded where many of the world's largest pharmaceutical companies have failed: in winning Food and Drug Administration approval for flibanserin, dubbed Addyi, the first drug to boost women's sexual desire. (Associated Press)
Photo by: Allen G. Breed
A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Sprout has succeeded where many of the world's largest pharmaceutical companies have failed: in winning Food and Drug Administration approval for flibanserin, dubbed Addyi, the first drug to boost women's sexual desire. (Associated Press)

Featured Photo Galleries